ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 41 filers reported holding ENZO BIOCHEM INC in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,422 | +31.3% | 1,731 | +72.6% | 0.00% | – |
Q2 2023 | $1,845 | -24.3% | 1,003 | 0.0% | 0.00% | – |
Q1 2023 | $2,437 | +143.7% | 1,003 | +37.8% | 0.00% | – |
Q4 2022 | $1,000 | -50.0% | 728 | 0.0% | 0.00% | – |
Q3 2022 | $2,000 | 0.0% | 728 | 0.0% | 0.00% | – |
Q2 2022 | $2,000 | -33.3% | 728 | -21.3% | 0.00% | – |
Q1 2022 | $3,000 | 0.0% | 925 | -5.3% | 0.00% | – |
Q4 2021 | $3,000 | -25.0% | 977 | 0.0% | 0.00% | – |
Q3 2021 | $4,000 | -20.0% | 977 | -43.5% | 0.00% | – |
Q2 2021 | $5,000 | -16.7% | 1,728 | 0.0% | 0.00% | – |
Q1 2021 | $6,000 | -25.0% | 1,728 | -40.8% | 0.00% | – |
Q4 2020 | $8,000 | -50.0% | 2,917 | -61.2% | 0.00% | – |
Q3 2020 | $16,000 | +128.6% | 7,526 | +148.7% | 0.00% | – |
Q2 2020 | $7,000 | -12.5% | 3,026 | 0.0% | 0.00% | – |
Q1 2020 | $8,000 | – | 3,026 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Roumell Asset Management, LLC | 2,436,771 | $7,822,000 | 10.43% |
VIEX Capital Advisors, LLC | 1,736,087 | $5,573,000 | 8.96% |
HARBERT FUND ADVISORS, INC. | 5,175,913 | $16,615,000 | 4.19% |
AMH Equity Ltd | 596,742 | $1,916,000 | 2.66% |
Potomac Capital Management, Inc. | 208,000 | $668,000 | 0.59% |
Agate Pass Investment Management, LLC | 24,292 | $78,000 | 0.05% |
RBF Capital, LLC | 250,359 | $804,000 | 0.05% |
KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $82,000 | 0.05% |
Corsair Capital Management | 58,657 | $188,000 | 0.04% |
BOOTHBAY FUND MANAGEMENT, LLC | 319,500 | $1,026,000 | 0.02% |